You have 9 free searches left this month | to do more

lazertinib

Lazertinib is a drug used to treat Carcinoma, Non-Small-Cell Lung, Healthy, and Metastatic Non Small Cell Lung Cancer. Lazertinib is being actively studied in 7 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCHosp. Gral. Univ. Gregorio Maranon
Memorial Sloan Kettering Cancer CenterHosp. Univ. Vall D Hebron
Beijing Cancer Hospital
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
  • Healthy
  • Lazertinib
  • +3 more
  • Salt Lake City, Utah
    PRA Health Sciences
2021-10-12
Oct 12, 2021
J
Completed
  • Healthy
  • Lazertinib
  • +2 more
  • Tempe, Arizona
    Celerion
2021-02-25
Feb 25, 2021
M
Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
2021-09-30
Sep 30, 2021
J
Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Lazertinib
  • Duarte, California
  • +8 more
2021-10-07
Oct 7, 2021
J
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Lazertinib
  • +3 more
  • Los Angeles, California
  • +82 more
2021-10-07
Oct 7, 2021
J
Recruiting
  • Non-Small-Cell Lung Cancer
  • Duarte, California
  • +95 more
2021-10-07
Oct 7, 2021